News | June 17, 2007

Kensey Nash Announces Results of Study Using the Thromcat Thrombectomy Catheter System

June 18, 2007 — Kensey Nash Corporation today announced that it has completed a European Union (EU) study to assess the device success, safety and performance of the ThromCat Thrombectomy Catheter System during percutaneous coronary intervention (PCI).

The trial enrolled over 60 patients at seven sites, and was designed to study outcomes of patients in both acute and elective PCI settings, who had thrombus present in their native coronary arteries.

The ThromCat System is a mechanical thrombectomy catheter designed to remove thrombus in patients, and is indicated in Europe for use in both coronary and certain peripheral arteries.

Hospital discharge results, presented by the company at the EuroPCR meeting in Barcelona last month, demonstrated over 90% device success, patient safety and desired device performance with 70% thrombus removal by volume. The results of the study also showed strong improvements to TIMI flow measurements, and myocardial blush scores, based on the use of the ThromCat System, with only 1.6% of the patients needing temporary pacing.

The ThromCat mechanical thrombectomy system is a fully disposable catheter system that incorporates HeliFlex technology to flush, macerate, and extract thrombus. An internal rotating helix creates a powerful vacuum to draw thrombus into the catheter and then macerate it, while simultaneously flushing the vessel to aid in the thrombus removal.

For more information: www.kenseynash.com

Related Content

Reflow Medical's Wingman Crossing Catheter Receives FDA Clearance for Coronary Indication
News | Catheters| October 02, 2017
October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S.
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
Teleflex, FDA 510k clearance, TrapLiner Catheter, U.S. launch
Technology | Catheters| March 02, 2017
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
Merit Medical Systems, SwiftNINJA Steerable Microcatheter, FDA 510(k) clearance
Technology | Catheters| November 09, 2016
November 9, 2016 — Merit Medical Systems Inc.
VentureMed Group, Flex Scoring Catheter, FDA approval, peripheral arterial disease, PAD, endovascular treatment
Technology | Catheters| July 13, 2016
July 13, 2016 — VentureMed Group Ltd., specializing in devices for the endovascular treatment of...
Roxwood Medical, MicroCross Catheter, full U.S. launch

Image courtesy of Roxwood Medical

Technology | Catheters| January 07, 2016
Roxwood Medical Inc. reported that more than 500 patients have been successfully treated as part of the initial limited...
Overlay Init